"10.1371_journal.pone.0053081","plos one","2013-01-04T00:00:00Z","Matthias Scheffler; Thomas Zander; Lucia Nogova; Carsten Kobe; Deniz Kahraman; Markus Dietlein; Irini Papachristou; Lukas Heukamp; Reinhard Büttner; Ron Boellaard; Adriaan A Lammertsma; Silvia Querings; Erich Stoelben; Walburga Engel-Riedel; Bernd Neumaier; Jürgen Wolf","Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln Bonn, Cologne, Germany; Clinic for Nuclear Medicine, University Hospital of Cologne, Cologne, Germany; Institute of Pathology, University Hospital Cologne, Cologne, Germany; Department of Nuclear Medicine and PET Research, VU University Medical Center Amsterdam, Amsterdam, The Netherlands; Max-Planck Institute for Neurological Research, Cologne, Germany; Lung Clinic Merheim, Hospital of Cologne, Cologne, Germany","Conceived and designed the experiments: MS TZ LN MD JW. Performed the experiments: MS TZ LN CK DK IP LH R. Büttner SQ BN JW. Analyzed the data: MS TZ. Contributed reagents/materials/analysis tools: MS TZ CK DK IP R. Boellaard AAL LH R. Büttner BN ES WER JW. Wrote the paper: MS TZ LN CK DK MD IP LH R. Boellaard R. Büttner AAL SQ ES WER BN JW.","During the termination phase of the trial, we have received research fundings from Roche, a commercial source. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Matthias Scheffler","MS",16,TRUE,5,8,2,9,TRUE,TRUE,TRUE,4,"11;12;13;15",TRUE
